Chief Scientific Officer

Dr. Shoemaker is an accomplished biomedical engineer with ten years of experience in development and application of three-dimensional (3D) tissue models in applied research and pharmaceutical testing. James is responsible for 3D cell-based assays, pre-clinical device R&D, scientific collaborations and partnering activities. He has published peer-reviewed articles focusing on tissue engineering, biomedical devices and biomaterials, and frequently presents at conferences and symposiums. James has developed an extraordinary number of forefront tissue models, using primary cells, secondary cells, and cell lines, spanning normal tissue models (brain, liver, kidney, bone, etc.) and diseased tissue models (neuroblastoma, cervical cancer, breast cancer, hepatoma, etc). Prior to joining Lena Biosciences, James held research positions at Emory University. Dr. Shoemaker holds a Ph.D. in Biomedical Engineering from Emory University and the Georgia Institute of Technology and a B.Sc. in Chemistry from the Georgia Institute of Technology.